公开(公告)号：US20200022984A1

公开(公告)日：2020-01-23

申请号：US16039916

申请日：2018-07-19

Applicant: Agency for Science, Technology and Research

Inventor： Zhenxun Wang ,  Wai Leong Tam ,  Lian Yee Yip ,  Ying Swan Ho ,  Zhengwei Wu ,  Bing Lim

IPC: A61K31/52 ,  A61P35/04 ,  C12Q1/6886 ,  A61K31/67 ,  A61K31/7105

Abstract: The present specification relates generally to a therapeutic protocol for treating a subject having cancer. Taught herein is a method of treating cancer or reducing the risk of recurrence of cancer in a subject following an anti-cancer therapy.

公开(公告)号：US11872230B2

公开(公告)日：2024-01-16

申请号：US17745292

申请日：2022-05-16

Applicant: Agency for Science, Technology and Research

Inventor： Zhenxun Wang ,  Wai Leong Tam ,  Lian Yee Yip ,  Ying Swan Ho ,  Zhengwei Wu ,  Bing Lim

IPC: C12Q1/6886 ,  A61K31/52 ,  A61P35/04 ,  A61K31/7105 ,  A61K31/67

CPC classification number: A61K31/52 ,  A61K31/67 ,  A61K31/7105 ,  A61P35/04 ,  C12Q1/6886 ,  C12Q2600/106 ,  C12Q2600/158

Abstract: The present invention relates generally to a therapeutic protocol for treating a subject having cancer. Taught herein is a method of treating cancer or reducing the risk of recurrence of cancer in a subject following an anti-cancer therapy.

公开(公告)号：US20220280520A1

公开(公告)日：2022-09-08

申请号：US17745292

申请日：2022-05-16

Applicant: Agency for Science, Technology and Research

Inventor： Zhenxun Wang ,  Wai Leong Tam ,  Lian Yee Yip ,  Ying Swan Ho ,  Zhengwei Wu ,  Bing Lim

IPC: A61K31/52 ,  A61P35/04 ,  A61K31/7105 ,  A61K31/67 ,  C12Q1/6886

Abstract: The present invention relates generally to a therapeutic protocol for treating a subject having cancer. Taught herein is a method of treating cancer or reducing the risk of recurrence of cancer in a subject following an anti-cancer therapy.

公开(公告)号：US11376256B2

公开(公告)日：2022-07-05

申请号：US16039916

申请日：2018-07-19

Applicant: Agency for Science, Technology and Research

Inventor： Zhenxun Wang ,  Wai Leong Tam ,  Lian Yee Yip ,  Ying Swan Ho ,  Zhengwei Wu ,  Bing Lim

IPC: A61K31/52 ,  A61P35/04 ,  A61K31/7105 ,  A61K31/67 ,  C12Q1/6886

Abstract: The present specification relates generally to a therapeutic protocol for treating a subject having cancer. Taught herein is a method of treating cancer or reducing the risk of recurrence of cancer in a subject following an anti-cancer therapy.